Skip to main
KALV
KALV logo

KalVista Pharma (KALV) Market Capitalization Overview

Market Cap: $644.32M as of Jun 13, 2025

$644.32M
Past Month+$80.54M (14.29%)
As of Jun 13, 2025, KalVista Pharma (KALV) has a market capitalization of $644.32M. Over the past 30 days, its market cap has decreased by -5%, while in the last 12 months, it has increased by 53.93%.

Market capitalization represents the total value of KalVista Pharma as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

KalVista Pharma (KALV) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of KalVista Pharma (KALV) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KalVista Pharma (KALV) Market Cap History

DateMarket CapChange
Jun 2, 2025$642.33M-5.00%
May 1, 2025$676.14M+21.92%
Apr 1, 2025$554.58M+3.24%
Mar 3, 2025$537.18M+17.90%
Feb 3, 2025$455.64M+4.06%
Jan 2, 2025$437.85M-12.49%

KalVista Pharma (KALV) End of Year Market Cap History

DateMarket CapChange
2025$644.32M+53.93%
2024$418.58M-1.13%
2023$423.35M+83.64%
2022$230.54M-28.79%
2021$323.74M-4.99%
2020$340.73M

FAQs About KalVista Pharma (KALV) Market Cap

As of Jun 13, 2025, the market capitalization of KalVista Pharma (KALV) is $644.32M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, KalVista Pharma’s market capitalization has increased by 14.29%, changing from $563.78M to $644.32M as of Jun 13, 2025.

In the last 3 months, KalVista Pharma’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, KalVista Pharma’s market capitalization decreased from $423.35M in January to $418.58M in December, reflecting a -1.13% change.

In the past five years, KalVista Pharma (KALV) has had a compound annual growth rate (CAGR) of 4.20% in market capitalization. This means its market cap has grown at an average rate of 4.20% per year.

KalVista Pharma (KALV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.